RT @VincentRK: These ideas are derived from a paper that @VPrasadMDMPH and I wrote on this topic. We need to move away from the blame game.…
19/n Pour plus d'informations sur l'influence des conflits d'intérêts en cancérologie. https://t.co/mG4HukgzXT
@chadinabhan @barttels2 @AaronGoodman33 @VincentRK @Rfonsi1 @szusmani Chadi, I would modify that statement to say 'I trust UNCONFLICTED MM experts in MM issues'. Vince and Vinay @VPrasadMDMPH wrote a 2016 article in #BCJ 'Conflict of interest in academic o
@stephaniemlee Conflict of interest are pervasive and shown to influence researchers conclusions @VPrasadMDMPH https://t.co/VdSKDctp7b
RT @ymori117: 3名のうちの1人、ラージクマール先生による利益相反の解説。 https://t.co/IXRCfhweIr
3名のうちの1人、ラージクマール先生による利益相反の解説。 https://t.co/IXRCfhweIr
RT @VincentRK: A lot of the answers to comments on this thread are addressed in detail in these two papers. Please read them if you truly w…
RT @VincentRK: A lot of the answers to comments on this thread are addressed in detail in these two papers. Please read them if you truly w…
"Besides direct financial conflicts of interest, there are other deeper conflicts that are built into the oncology system perhaps in a more systemic manner than in other fields of medicine." Blood Cancer Journal https://t.co/b6V4USLrlc
RT @VincentRK: A lot of the answers to comments on this thread are addressed in detail in these two papers. Please read them if you truly w…
A lot of the answers to comments on this thread are addressed in detail in these two papers. Please read them if you truly want to help and to get to the rationale behind the recommendations. https://t.co/bvf7pQpGW1 https://t.co/XA5jIo03bc
RT @VincentRK: These ideas are derived from a paper that @VPrasadMDMPH and I wrote on this topic. We need to move away from the blame game.…
These ideas are derived from a paper that @VPrasadMDMPH and I wrote on this topic. We need to move away from the blame game. #BCJ https://t.co/XA5jIo03bc
RT @pash22: Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward https://t.co/escqnpoYRh via…
RT @ymori117: がん医療における利益相反についての簡潔な論説: COI in academic oncology: moving beyond the blame game and forging a path forward https://t.co/dDzjg8…
RT @ymori117: がん医療における利益相反についての簡潔な論説: COI in academic oncology: moving beyond the blame game and forging a path forward https://t.co/dDzjg8…
RT @ymori117: がん医療における利益相反についての簡潔な論説: COI in academic oncology: moving beyond the blame game and forging a path forward https://t.co/dDzjg8…
RT @ymori117: がん医療における利益相反についての簡潔な論説: COI in academic oncology: moving beyond the blame game and forging a path forward https://t.co/dDzjg8…
RT @ymori117: がん医療における利益相反についての簡潔な論説: COI in academic oncology: moving beyond the blame game and forging a path forward https://t.co/dDzjg8…
RT @ymori117: がん医療における利益相反についての簡潔な論説: COI in academic oncology: moving beyond the blame game and forging a path forward https://t.co/dDzjg8…
RT @VincentRK: Would be great to know if any expert disagrees with these recommendations and why. We think these are reasonable and you can…
Excellent commentary and proposals.
RT @pash22: Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward https://t.co/escqnpoYRh via…
Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward https://t.co/escqnpoYRh via @VincentRK & @VPplenarysesh @Maherjane @CR_UK
RT @DrGlenWeiss: Good recommendations in this piece published in blood cancer j @VPrasadMDMPH @VincentRK https://t.co/XeztEPnnQG
Would be great to know if any expert disagrees with these recommendations and why. We think these are reasonable and you can continue to work with any or all companies you want. @mtmdphd @ASCOPost
RT @VPrasadMDMPH: The most realistic next step to improve conflict of interest is to engage in this modest proposal by @VincentRK and I T…
RT @DrGlenWeiss: Good recommendations in this piece published in blood cancer j @VPrasadMDMPH @VincentRK https://t.co/XeztEPnnQG
RT @DrGlenWeiss: Good recommendations in this piece published in blood cancer j @VPrasadMDMPH @VincentRK https://t.co/XeztEPnnQG
RT @DrGlenWeiss: Good recommendations in this piece published in blood cancer j @VPrasadMDMPH @VincentRK https://t.co/XeztEPnnQG
RT @DrGlenWeiss: Good recommendations in this piece published in blood cancer j @VPrasadMDMPH @VincentRK https://t.co/XeztEPnnQG
Good recommendations in this piece published in blood cancer j @VPrasadMDMPH @VincentRK
RT @VincentRK: These are not extreme proposals: https://t.co/XA5jIo03bc 1/ https://t.co/QxzE04rWiu
These are not extreme proposals: https://t.co/XA5jIo03bc 1/ https://t.co/QxzE04rWiu
RT @HengartnerMP: @matthewarcher5 @Chickenlodge @J_EJ_Buckman @CoyneoftheRealm We should not dismiss such research. But we should interpret…
RT @HengartnerMP: @matthewarcher5 @Chickenlodge @J_EJ_Buckman @CoyneoftheRealm We should not dismiss such research. But we should interpret…
RT @HengartnerMP: @matthewarcher5 @Chickenlodge @J_EJ_Buckman @CoyneoftheRealm We should not dismiss such research. But we should interpret…
@matthewarcher5 @Chickenlodge @J_EJ_Buckman @CoyneoftheRealm We should not dismiss such research. But we should interpret cautiously. And surely it‘s no cospiracy. Hundreds of papers have shown that COI can corrupt the dissemination and implementation of b
RT @ymori117: がん医療における利益相反についての簡潔な論説: COI in academic oncology: moving beyond the blame game and forging a path forward https://t.co/dDzjg8…
RT @ymori117: がん医療における利益相反についての簡潔な論説: COI in academic oncology: moving beyond the blame game and forging a path forward https://t.co/dDzjg8…
RT @ymori117: がん医療における利益相反についての簡潔な論説: COI in academic oncology: moving beyond the blame game and forging a path forward https://t.co/dDzjg8…
RT @ymori117: がん医療における利益相反についての簡潔な論説: COI in academic oncology: moving beyond the blame game and forging a path forward https://t.co/dDzjg8…
RT @ymori117: がん医療における利益相反についての簡潔な論説: COI in academic oncology: moving beyond the blame game and forging a path forward https://t.co/dDzjg8…
がん医療における利益相反についての簡潔な論説: COI in academic oncology: moving beyond the blame game and forging a path forward https://t.co/dDzjg8aHVw
There is a big problem with COI in Medicine. No doubt. But focus on the real problem: check out https://t.co/K6ruURY52o https://t.co/iqkEz5bxVn
RT @GAPPTeam: Our comments on Blood Cancer Journal editorial suggesting banning professional medical writers to reduce COI https://t.co/fK1…
RT @GAPPTeam: Our comments on Blood Cancer Journal editorial suggesting banning professional medical writers to reduce COI https://t.co/fK1…
RT @GAPPTeam: Our comments on Blood Cancer Journal editorial suggesting banning professional medical writers to reduce COI https://t.co/fK1…
RT @GAPPTeam: Our comments on Blood Cancer Journal editorial suggesting banning professional medical writers to reduce COI https://t.co/fK1…
RT @GAPPTeam: Our comments on Blood Cancer Journal editorial suggesting banning professional medical writers to reduce COI https://t.co/fK1…
RT @GAPPTeam: Our comments on Blood Cancer Journal editorial suggesting banning professional medical writers to reduce COI https://t.co/fK1…
RT @GAPPTeam: Our comments on Blood Cancer Journal editorial suggesting banning professional medical writers to reduce COI https://t.co/fK1…
Our comments on Blood Cancer Journal editorial suggesting banning professional medical writers to reduce COI https://t.co/fK1pVTtDxs #ismpp
Comment on Prasad V (2016): Conflict of interest in academic oncology: moving beyond the blame game and forging https://t.co/oc9XF6sxyd
.@VinayPrasad82 and I explain why #FCOI is a big problem in Oncology & proposals to consider. @mtmdphd @BERector https://t.co/7EgCg8qVHi
RT @Vilavaite: Financial Conflicts in #Oncology can influence treatment, cost and toxicity #COI https://t.co/v1X9bREwDO Via @VinayPrasad82…
RT @Vilavaite: Financial Conflicts in #Oncology can influence treatment, cost and toxicity #COI https://t.co/v1X9bREwDO Via @VinayPrasad82…
RT @Vilavaite: Financial Conflicts in #Oncology can influence treatment, cost and toxicity #COI https://t.co/v1X9bREwDO Via @VinayPrasad82…
RT @Vilavaite: Financial Conflicts in #Oncology can influence treatment, cost and toxicity #COI https://t.co/v1X9bREwDO Via @VinayPrasad82…
RT @Vilavaite: Financial Conflicts in #Oncology can influence treatment, cost and toxicity #COI https://t.co/v1X9bREwDO Via @VinayPrasad82…
RT @Vilavaite: Financial Conflicts in #Oncology can influence treatment, cost and toxicity #COI https://t.co/v1X9bREwDO Via @VinayPrasad82…
I think it'll backfire. Every mud lobbed at Mr Trump backfires https://t.co/pxqAlUqONE
cc: @ASH_hematology @ASCO @ASCOPost @TheLancetOncol @BloodJournal @DrJulieVose - Hope you can implement @mtmdphd https://t.co/7EgCg89kPK https://t.co/81SMQZ27oH
RT @VincentRK: Editorial On COI #OpenAccess in #BCJ @SpringerNature #NaturePublishingGroup @VinayPrasad82 @fischmd @MayoClinic https://t.co…
Conflict of interest in academic #oncology https://t.co/zkRji0em1o
RT @Vilavaite: Financial Conflicts in #Oncology can influence treatment, cost and toxicity #COI https://t.co/v1X9bREwDO Via @VinayPrasad82…
RT @corinne_malanca: #Finacial Conflicts in #Oncology? @upatientsgroup @SU2C @ChildhoodCancer @NoBrainCancer https://t.co/GiinFighDO! http…
RT @VincentRK: Most experts may be free of bias. Problem with financial COI is that its impossible to determine who is & who isnt conflicte…
RT @VincentRK: Can you tell if an expert recommendation in a review/editorial is influenced or not by 10s of 1000s $ in honoraria? https://…
RT @VincentRK: Most experts may be free of bias. Problem with financial COI is that its impossible to determine who is & who isnt conflicte…
Most experts may be free of bias. Problem with financial COI is that its impossible to determine who is & who isnt conflicted @VinayPrasad82 https://t.co/Y7uevQclt9
RT @VincentRK: Can you tell if an expert recommendation in a review/editorial is influenced or not by 10s of 1000s $ in honoraria? https://…
Can you tell if an expert recommendation in a review/editorial is influenced or not by 10s of 1000s $ in honoraria? https://t.co/uYBAUDqhu2
Vinay Prasad: Why financial conflict is a special problem in oncology https://t.co/Dfx7k6BOKB …: Why… https://t.co/UsOSQAXrcY #MedicBoard https://t.co/L2B40pQBF1
RT @VinayPrasad82: Financial Conflicts in Oncology; Pervasive and problematic. @VincentRK & I try to find some middle ground https://t.c…
#ConflictOfInterest in academic oncology: moving beyond the blame game and forging a path forward https://t.co/9MvoMMKZ5j
Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward: https://t.co/xrkudp9Uim
RT @GLamasMD: Disclosure of COI does not eliminate the conflict. Also provides no guidance for reader. https://t.co/gQ8KCcUtY0
RT @GLamasMD: Disclosure of COI does not eliminate the conflict. Also provides no guidance for reader. https://t.co/gQ8KCcUtY0
RT @dyctiostelium: Conflict of interest in #cancer #medicine: complicated & important. For instance, #pharma sponsored #ghostwriters https:…
RT @dyctiostelium: Conflict of interest in #cancer #medicine: complicated & important. For instance, #pharma sponsored #ghostwriters https:…
RT @dyctiostelium: Conflict of interest in #cancer #medicine: complicated & important. For instance, #pharma sponsored #ghostwriters https:…
RT @dalmorgan: We increasingly hear pleas for the use of "life-saving drugs" (really "adding a small increment"): this article sets a good…
RT @fgomollon: @VinayPrasad82 THANKS for this exceptional piece.As an academic with COI (not in oncology)I fully support your views https:/…
RT @dyctiostelium: Conflict of interest in #cancer #medicine: complicated & important. For instance, #pharma sponsored #ghostwriters https:…
Conflict of interest in #cancer #medicine: complicated & important. For instance, #pharma sponsored #ghostwriters https://t.co/CensUrRo3d
RT @RHRLeBlanc: Conflict of interest in academic oncology @cherejoblo https://t.co/s7LXhnwwsu
RT @RHRLeBlanc: Conflict of interest in academic oncology @cherejoblo https://t.co/s7LXhnwwsu
Who disagrees with this stuff? Unless you're the problem, and you're looking out for yourself/career .. there is nothing to argue with here. https://t.co/fx2lOBYnSe
RT @VincentRK: Conflict of Interest in oncology-Big problem @VinayPrasad82 @mtmdphd @DrMJoyner @BERector @ASlavitt BCJ #openaccess https:/…
Vinay Prasad: Why financial conflict is a special problem in oncology https://t.co/Dfx7k6BOKB …: Why… https://t.co/VtJhY3o0JK #MedicBoard https://t.co/ddWqDmGhEb